Can I read Percutaneous Cryoablation of Subcapsular Hepatocellular Carcinoma: a Retrospective Study of 57 Cases on EtoBox?

Percutaneous Cryoablation of Subcapsular Hepatocellular Carcinoma: a Retrospective Study of 57 Cases by Fuming Wang; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China; Jianbing Ma; Linlin Wu; Na Li; Rong Luo; Guangxu Wei; Jijin Yang; Department of Radiology, The First Hospital of Jiaxing, Zhejiang, China; Department of Oncology, Tengzhou Central People’s Hospital, Shandong, China; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, ChinaDepartment of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China is a Medicine article available to read on EtoBox.

What is Percutaneous Cryoablation of Subcapsular Hepatocellular Carcinoma: a Retrospective Study of 57 Cases about?

PURPOSE This study aims to evaluate the safety and effectiveness of the percutaneous cryoablation for subcapsular hepatocellular carcinoma (HCC). METHODS A total of 57 patients with subcapsular (<1 cm form the liver edge) HCCs (68 lesions), who were treated with CT-guided percutaneous cryoablation in the Department of Interventional Radiology of our hospital between July 1, 2016 and September 1, 2018, were retrospectively included. Complete ablation rate, local tumor progression (LTP) and treatment-related complications were evaluated. Furthermore, the degree of intraoperative and postoperative pain was measured with the visual analog scale (VAS), and laboratory findings were compared before and after the procedure. RESULTS All patients successfully completed the treatment. The mean follow-up period was 12.8 months (range, 3-27 months), and the complete ablation rate was 97% (66/68). Local tumor progression occurred in 11 lesions (16.2%), and the 6-, 12- and 18-month cumulative LTP rates were 4.0%, 8.2% and 20.5%, respectively. Two patients (3.5%, 2/57) developed major complications, and 12 patients had minor complications (22.8%, 12/57). The mean VAS score during the operation was

Who reads Percutaneous Cryoablation of Subcapsular Hepatocellular Carcinoma: a Retrospective Study of 57 Cases?

Author

Fuming Wang; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China; Jianbing Ma; Linlin Wu; Na Li; Rong Luo; Guangxu Wei; Jijin Yang; Department of Radiology, The First Hospital of Jiaxing, Zhejiang, China; Department of Oncology, Tengzhou Central People’s Hospital, Shandong, China; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, ChinaDepartment of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China

Publisher

Galenos Yayinevi

Published

2019

Language

EN

Field

Medicine (Health Sciences)